Literature DB >> 32267503

Optimizable Risk Factors Contributing to Mortality in Patients With Heart Failure Undergoing Noncardiac Surgery.

Benjamin J Lerman1, Edward H Livingston2, Sherry M Wren3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32267503      PMCID： PMC7142792          DOI： 10.1001/jamasurg.2020.0257

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  5 in total

1.  Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure.

Authors:  John G F Cleland; Jufen Zhang; Pierpaolo Pellicori; Ben Dicken; Riet Dierckx; Ahmad Shoaib; Kenneth Wong; Alan Rigby; Kevin Goode; Andrew L Clark
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

2.  Association of Left Ventricular Ejection Fraction and Symptoms With Mortality After Elective Noncardiac Surgery Among Patients With Heart Failure.

Authors:  Benjamin J Lerman; Rita A Popat; Themistocles L Assimes; Paul A Heidenreich; Sherry M Wren
Journal:  JAMA       Date:  2019-02-12       Impact factor: 56.272

Review 3.  Practical Guide to Surgical Data Sets: Veterans Affairs Surgical Quality Improvement Program (VASQIP).

Authors:  Nader N Massarweh; Amy H Kaji; Kamal M F Itani
Journal:  JAMA Surg       Date:  2018-08-01       Impact factor: 14.766

4.  Little effect of insurance status or socioeconomic condition on disparities in minority appendicitis perforation rates.

Authors:  Edward H Livingston; Robert W Fairlie
Journal:  Arch Surg       Date:  2012-01

5.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Authors:  Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker
Journal:  Eur Heart J       Date:  2014-08-31       Impact factor: 29.983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.